Skip to main content
. 2022 Jun 27;15:1157–1173. doi: 10.2147/CCID.S357810

Table 5.

Adverse Events

Adverse Events (AE) Intensity n related to Treatment
Total number of AEs in 380 treatments: 36 (9.5%)
Injection sites: Hematoma Mild 16
Injection sites: Hematoma Moderate 1
Injection sites: Redness Mild 5
Injection sites: Swelling Mild 5
Injection sites: Swelling Moderate 1
Injection sites: Pain Mild 4
Urticaria Mild 3
Urticaria Moderate 1